Clinical Trials
2 trialsNCT02513667 2023-02-03
Ceritinib in Combination With Stereotactic Ablative Radiation Metastatic Lung Adenocarcinoma
University of Texas Southwestern Medical Center
Phase 2 Terminated
NCT02587650 2020-01-27
Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma
University of California, San Francisco
Phase 2 Terminated